Rivaroxaban, in addition to low-dose aspirin, significantly reduced the occurrence of total severe events of the heart, limb or brain and issues related to other vascular complications in patients with symptomatic peripheral artery disease (PAD) who underwent lower extremity revascularization, a procedure to open blocked arteries in the leg.
- Read more about Rivaroxaban Reduces First and Total Ischemic Events in Patients with Peripheral Artery Disease
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2021/rivaroxaban-reduces-first-and-total-ischemic-events-in-patients-with-peripheral-artery-disease
No comments:
Post a Comment